Hilary Frayer is global healthcare leader renowned for her expertise in medical affairs and strategic initiatives, having garnered extensive experience in enhancing medical education programs, cultivating relationships with key opinion leaders, and guiding evidence-based healthcare decisions. Hilary’s comprehensive background in hematology, oncology, and molecular diagnostics has equipped her with the ability to effectively convey intricate scientific data to diverse audiences. Throughout her career, Hilary has spearheaded programs that have significantly influenced medical affairs, including the development of impactful medical education programs, the publication of scientific papers, and the enrollment of clinical trials.
In prior roles, Hilary has demonstrated a talent for nurturing relationships with key opinion leaders, facilitating scientific exchange, and contributing to the advancement of genomic-based testing in dermatologic oncology. Her dedication to excellence in medical affairs has been duly recognized for outstanding contributions. In addition to serving as Medical Science Liaison with Delphi-Diagnostics, Hilary also occupies a leadership position at Quest Diagnostics, where she continues to drive transformative initiatives that propel medical objectives forward and bolster informed healthcare decisions. Hilary’s unwavering commitment to quality, compliance, and innovation in medical affairs underscores her resolve to enhance patient outcomes and champion medical progress in the healthcare industry.